Login / Signup

Correction: Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis.

Ji-Nuo WangTing LiuAi-Lin ZhaoBo-Ju PanJian SunJian LiDao-Bin ZhouXin-Xin CaoMing-Hui Duan
Published in: Leukemia (2023)
Keyphrases
  • high dose
  • low dose
  • single cell
  • cell therapy
  • open label
  • randomized controlled trial
  • double blind
  • mesenchymal stem cells
  • study protocol